Chemotherapy ‘Has Limited Role’ After ICI Failure in Metastatic Melanoma
The objective response rate was 12.5%, and the median progression-free survival was 2.6 months.
Cancer
COVID-19 and Lung Cancer: What We Know and Don’t Know
Researchers have summarized what is known about COVID-19 in the context of lung cancer and highlighted areas where more research is needed.
Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19
SABCS: Black Race Predicts Breast Cancer-Related Lymphedema
Other independent predictors of BCRL include receipt of neoadjuvant chemotherapy, older age, increasing amount of time since surgery
Blacks, Hispanics Still Underrepresented in Cancer Clinical Trials
Black and Hispanic patients remain underrepresented in cancer trials, despite increased participation from 2015 to 2019.
Unemployment Adversely Linked to Recommended Cancer Screening
Unemployment is adversely associated with recommended cancer screening, with the association explained by lack of health insurance.
Patient Economic Burden for Cancer Care $21.1 Billon in 2019
Patient economic burden associated with cancer care was projected to be $21.1 billion in 2019.
3% of US Cancer Cases Attributable to Physical Inactivity
The proportion of all incident cancer cases attributable to physical inactivity is 3.0% overall and varies between states from 2.3 to 3.7%.
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Racial/Ethnic Minorities Have Higher Risk for Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...